Singapore approves COVID-19 vaccine to be used in 12 to 15-year-olds


Singapore, May 18

Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.

“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population,” the health ministry said in a statement, adding “its safety profile is also consistent with the known safety profile in the adult population”.

The government will also extend the interval between two-dose Covid-19 vaccines to six to eight weeks, from three to four weeks currently, it said. — Reuters



Be the first to comment on "Singapore approves COVID-19 vaccine to be used in 12 to 15-year-olds"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: